The Deputy Director for Safety at the FDA’s Division of Psychiatry Products answers my questions about how the risks of psychiatric drugs are evaluated by health regulators – and explains what you need to know to better protect yourself. Read the whole article or listen to an audio version of the interview at the Inner Compass Initiative website. (Note that while psychiatric drugs are the focus, much of our discussion generally applies to any other drugs as well.)